Skip to main content
SpringerLink
Log in

Colorectal Cancer: Management of Local Recurrence

  • Chapter
  • First Online:
The ASCRS Textbook of Colon and Rectal Surgery

  • 66k Accesses

Abstract

Local recurrence after surgery for colorectal cancer remains a challenging clinical problem. Modern imaging has allowed for better patient selection and gives the surgeon a higher degree of certainty about his or her ability to achieve a curative resection. Indications for surgery in patients with local recurrence have expanded to include patients with higher sacral involvement and extensive pelvic sidewall disease. Given the risks associated with increasingly more complex operations, several centers around the world have developed organized multidisciplinary teams of expert surgeons to make operating safer and more efficient. Surgery that achieves a negative-margin resection remains the universal predictor of oncologic outcome in patients with local recurrence. Improved surgical technique and the appropriate use of chemotherapy and radiation have led to increasingly better oncologic outcomes over the past 20 years. Postoperative morbidity remains high in patients with local recurrence and negatively impacts their quality of life. New strategies to mitigate morbidity should be the focus of future research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Cripps H. Rectal cancer: rectal excision for cancer: the selection of suitable cases and prognosis. BMJ. 1892;10(2):1277–9.

    Google Scholar 

  2. Mayo CH. Cancer of the large bowel. Med Sentinel. 1904;12:466–73.

    Google Scholar 

  3. Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon. Lancet. 1908;2:1812–3.

    Google Scholar 

  4. Mayo WJ. Grafting and traumatic dissemination of carcinoma in the course of operations for malignant disease. JAMA. 1913;60(7):512–3.

    Google Scholar 

  5. Sugarbaker ED. Coincident removal of additional structures in resections for carcinoma of the colon and rectum. Ann Surg. 1946;123(6):1036–46.

    PubMed  PubMed Central  Google Scholar 

  6. Dixon CF. Anterior resection for malignant lesions of the upper part of the rectum and lower part of the sigmoid. Ann Surg. 1948;128:425–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1(8496):1479–82.

    CAS  PubMed  Google Scholar 

  8. Mathis KL, Larson DW, Dozois EJ, Cima RR, Huebner M, Haddock MG, et al. Outcomes following surgery without radiotherapy for rectal cancer. Br J Surg. 2012;99(1):137–43.

    CAS  PubMed  Google Scholar 

  9. Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, et al. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol. 2014;15(2):184–90.

    CAS  PubMed  Google Scholar 

  10. Gray J. Evaluation of conservative resection with end to end anastomosis for carcinoma of the rectum and lower sigmoid colon. Arch Surg. 1948;57(3):361–72.

    CAS  Google Scholar 

  11. Lofgren EP, Waugh JM, Dockerty MB. Local recurrence of carcinoma after anterior resection of the rectum and the sigmoid; relationship with the length of normal mucosa excised distal to the lesion. AMA Arch Surg. 1957;74(6):825–38.

    CAS  PubMed  Google Scholar 

  12. Pollard SG, Macfarlane R, Everett WG. Surgery for recurrent colorectal carcinoma—is it worthwhile? Ann R Coll Surg Engl. 1989;71(5):293–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum. 1996;39(12):1379–95.

    CAS  PubMed  Google Scholar 

  14. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg. 1994;220(4):586–95. discussion 95-7.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O’Connell MJ, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg. 2003;237(4):502–8.

    PubMed  PubMed Central  Google Scholar 

  16. Suzuki K, Dozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39(7):730–6.

    CAS  PubMed  Google Scholar 

  17. Colibaseanu DT, Dozois EJ, Mathis KL, Rose PS, Ugarte ML, Abdelsattar ZM, et al. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Dis Colon Rectum. 2014;57(1):47–55.

    PubMed  Google Scholar 

  18. Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD, et al. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies. Dis Colon Rectum. 2014;57(10):1153–61.

    PubMed  Google Scholar 

  19. Konski AA, Suh WW, Herman JM, Blackstock Jr AW, Hong TS, Poggi MM, et al. ACR appropriateness criteria(R)-recurrent rectal cancer. Gastrointest Cancer Res. 2012;5(1):3–12.

    PubMed  PubMed Central  Google Scholar 

  20. Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum. 2000;43(12):1695–701. discussion 701-3.

    CAS  PubMed  Google Scholar 

  21. Haddock MG, Gunderson LL, Nelson H, Cha SS, Devine RM, Dozois RR, et al. Intraoperative irradiation for locally recurrent colorectal cancer in previously irradiated patients. Int J Radiat Oncol Biol Phys. 2001;49(5):1267–74.

    CAS  PubMed  Google Scholar 

  22. Sjovall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007;14(2):432–40.

    PubMed  Google Scholar 

  23. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.

    Google Scholar 

  24. Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol. 2010;17(5):1343–56.

    PubMed  Google Scholar 

  25. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer. 1974;34(4):1278–92.

    CAS  PubMed  Google Scholar 

  26. McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis. 1995;10(3):126–32.

    CAS  PubMed  Google Scholar 

  27. Wanebo HJ, Antoniuk P, Koness RJ, Levy A, Vezeridis M, Cohen SI, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum. 1999;42(11):1438–48.

    CAS  PubMed  Google Scholar 

  28. McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg. 1985;72(1):34–7.

    CAS  PubMed  Google Scholar 

  29. Eroglu A, Camlibel S. Risk factors for locoregional recurrence of scar carcinoma. Br J Surg. 1997;84(12):1744–6.

    CAS  PubMed  Google Scholar 

  30. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998;227(2):157–67.

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Bulow S, Christensen IJ, Iversen LH, Harling H, Danish Colorectal Cancer G. Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis. 2011;13(11):1256–64.

    CAS  PubMed  Google Scholar 

  32. Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, van den Brule AJ, et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol. 2009;35(10):1071–7.

    CAS  PubMed  Google Scholar 

  33. Kuru B, Camlibel M, Dinc S, Gulcelik MA, Gonullu D, Alagol H. Prognostic factors for survival in breast cancer patients who developed distant metastasis subsequent to definitive surgery. Singapore Med J. 2008;49(11):904–11.

    CAS  PubMed  Google Scholar 

  34. Dogan L, Karaman N, Yilmaz KB, Ozaslan C, Atalay C, Altinok M. Characteristics and risk factors for colorectal cancer recurrence. J BUON. 2010;15(1):61–7.

    CAS  PubMed  Google Scholar 

  35. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235(4):449–57.

    PubMed  PubMed Central  Google Scholar 

  36. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26(2):303–12.

    PubMed  Google Scholar 

  37. Monson JR, Weiser MR, Buie WD, Chang GJ, Rafferty JF, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013;56(5):535–50.

    CAS  PubMed  Google Scholar 

  38. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD, Standards Practice Task Force of the American Society of C, et al. Practice parameters for the management of colon cancer. Dis Colon Rectum. 2012;55(8):831–43.

    PubMed  Google Scholar 

  39. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum. 2005;48(5):929–37.

    PubMed  Google Scholar 

  40. Colibaseanu DT, Mathis KL, Abdelsattar ZM, Larson DW, Haddock MG, Dozois EJ. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis? Dis Colon Rectum. 2013;56(1):14–9.

    PubMed  Google Scholar 

  41. Dozois EJ, Privitera A, Holubar SD, Aldrete JF, Sim FH, Rose PS, et al. High sacrectomy for locally recurrent rectal cancer: can long-term survival be achieved? J Surg Oncol. 2011;103(2):105–9.

    CAS  PubMed  Google Scholar 

  42. Milne T, Solomon MJ, Lee P, Young JM, Stalley P, Harrison JD. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg. 2013;258(6):1007–13.

    PubMed  Google Scholar 

  43. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg. 1996;83(3):293–304.

    CAS  PubMed  Google Scholar 

  44. Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med. 2001;28(12):1758–65.

    CAS  PubMed  Google Scholar 

  45. Moore HG, Akhurst T, Larson SM, Minsky BD, Mazumdar M, Guillem JG. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg. 2003;197(1):22–8.

    PubMed  Google Scholar 

  46. Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43(6):759–67. discussion 67-70.

    CAS  PubMed  Google Scholar 

  47. Ogunbiyi OA, Flanagan FL, Dehdashti F, Siegel BA, Trask DD, Birnbaum EH, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol. 1997;4(8):613–20.

    CAS  PubMed  Google Scholar 

  48. Chessin DB, Kiran RP, Akhurst T, Guillem JG. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg. 2005;201(6):948–56.

    PubMed  Google Scholar 

  49. Simo M, Lomena F, Setoain J, Perez G, Castellucci P, Costansa JM, et al. FDG-PET improves the management of patients with suspected recurrence of colorectal cancer. Nucl Med Commun. 2002;23(10):975–82.

    CAS  PubMed  Google Scholar 

  50. Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 1994;37(3):272–7.

    CAS  PubMed  Google Scholar 

  51. Older P, Smith R. Experience with the preoperative invasive measurement of haemodynamic, respiratory and renal function in 100 elderly patients scheduled for major abdominal surgery. Anaesth Intensive Care. 1988;16(4):389–95.

    CAS  PubMed  Google Scholar 

  52. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988;94(6):1176–86.

    CAS  PubMed  Google Scholar 

  53. Bass EM, Del Pino A, Tan A, Pearl RK, Orsay CP, Abcarian H. Does preoperative stoma marking and education by the enterostomal therapist affect outcome? Dis Colon Rectum. 1997;40(4):440–2.

    CAS  PubMed  Google Scholar 

  54. Haugen V, Bliss DZ, Savik K. Perioperative factors that affect long-term adjustment to an incontinent ostomy. J Wound Ostomy Continence Nurs. 2006;33(5):525–35.

    PubMed  Google Scholar 

  55. Nugent KP, Daniels P, Stewart B, Patankar R, Johnson CD. Quality of life in stoma patients. Dis Colon Rectum. 1999;42(12):1569–74.

    CAS  PubMed  Google Scholar 

  56. Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg. 2009;96(2):191–6.

    CAS  PubMed  Google Scholar 

  57. Sagar PM. Ultraradical resection for locally recurrent rectal cancer. Dis Colon Rectum. 2014;57(1):1–2.

    PubMed  Google Scholar 

  58. Stocchi L, Nelson H, Sargent DJ, Engen DE, Haddock MG. Is en-bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated? Ann Surg Oncol. 2006;13(5):740–4.

    PubMed  Google Scholar 

  59. Cima RR. Rectal cancer: locally advanced and recurrent. In: Beck ED, Roberts PL, Saclarides TJ, Senagore AJ, Stamos MJ, Wexner SD, editors. The ASCRS textbook of colon and rectal surgery. 2nd ed. New York: Springer; 2011. p. 761–72.

    Google Scholar 

  60. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer. Surg Oncol Clin N Am. 2005;14(2):225–38.

    PubMed  Google Scholar 

  61. Beyond TMEC. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009–14.

    Google Scholar 

  62. Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases. Dis Colon Rectum. 2005;48(5):897–909.

    PubMed  Google Scholar 

  63. Taylor WE, Donohue JH, Gunderson LL, Nelson H, Nagorney DM, Devine RM, et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann Surg Oncol. 2002;9(2):177–85.

    PubMed  Google Scholar 

  64. Torricelli P, Pecchi A, Luppi G, Romagnoli R. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging. 2003;28(1):19–27.

    CAS  PubMed  Google Scholar 

  65. Colosio A, Soyer P, Rousset P, Barbe C, Nguyen F, Bouche O, et al. Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer. J Magn Reson Imaging. 2014;40(2):306–13.

    PubMed  Google Scholar 

  66. Haddock MG, Miller RC, Nelson H, Pemberton JH, Dozois EJ, Alberts SR, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys. 2011;79(1):143–50.

    PubMed  Google Scholar 

  67. Heriot AG, Byrne CM, Lee P, Dobbs B, Tilney H, Solomon MJ, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum. 2008;51(3):284–91.

    PubMed  Google Scholar 

  68. Dresen RC, Gosens MJ, Martijn H, Nieuwenhuijzen GA, Creemers G-J, Daniels-Gooszen AW, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol. 2008;15(7):1937–47.

    PubMed  PubMed Central  Google Scholar 

  69. Abdelsattar ZM, Mathis KL, Colibaseanu DT, Merchea A, Bower TC, Larson DW, et al. Surgery for locally advanced recurrent colorectal cancer involving the aortoiliac axis: can we achieve R0 resection and long-term survival? Dis Colon Rectum. 2013;56(6):711–6.

    PubMed  Google Scholar 

  70. Hugate Jr RR, Dickey ID, Phimolsarnti R, Yaszemski MJ, Sim FH. Mechanical effects of partial sacrectomy: when is reconstruction necessary? Clin Orthop Relat Res. 2006;450:82–8.

    PubMed  Google Scholar 

  71. Dickey ID, Hugate Jr RR, Fuchs B, Yaszemski MJ, Sim FH. Reconstruction after total sacrectomy: early experience with a new surgical technique. Clin Orthop Relat Res. 2005;438:42–50.

    PubMed  Google Scholar 

  72. Chessin DB, Hartley J, Cohen AM, Mazumdar M, Cordeiro P, Disa J, et al. Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol. 2005;12(2):104–10.

    PubMed  Google Scholar 

  73. Radice E, Nelson H, Mercill S, Farouk R, Petty P, Gunderson L. Primary myocutaneous flap closure following resection of locally advanced pelvic malignancies. Br J Surg. 1999;86(3):349–54.

    CAS  PubMed  Google Scholar 

  74. Sullivan PS, Dozois EJ. Exenterative surgery and reconstruction. In: Zbar AP, Madoff RD, Wexner SD, editors. Reconstructive surgery of the rectum, anus and perineum. London: Springer; 2013. p. 137–53.

    Google Scholar 

  75. Liebermann-Meffert D. The greater omentum. Anatomy, embryology, and surgical applications. Surg Clin North Am. 2000;80(1):275–93.

    CAS  PubMed  Google Scholar 

  76. Harji DP, Sagar PM, Boyle K, Griffiths B, McArthur DR, Evans M. Surgical resection of recurrent colonic cancer. Br J Surg. 2013;100(7):950–8.

    CAS  PubMed  Google Scholar 

  77. Nielsen M, Rasmussen P, Pedersen B, Hagemann-Madsen R, Lindegaard J, Laurberg S. Early and late outcomes of surgery for locally recurrent rectal cancer: a prospective 10-year study in the total mesorectal excision era. Ann Surg Oncol. 2015;22(8):2677–84.

    Google Scholar 

  78. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245(5):726–33.

    PubMed  PubMed Central  Google Scholar 

  79. Bikhchandani J, Ong GK, Dozois EJ, Mathis KL. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer. Dis Colon Rectum. 2015;58(3):283–7.

    Google Scholar 

  80. You YN, Roses RE, Chang GJ, Rodriguez-Bigas MA, Feig BW, Slack R, et al. Multimodality salvage of recurrent disease after local excision for rectal cancer. Dis Colon Rectum. 2012;55(12):1213–9.

    PubMed  Google Scholar 

  81. Bhangu A, Ali SM, Darzi A, Brown G, Tekkis P. Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer. Colorectal Dis. 2012;14(12):1457–66.

    CAS  PubMed  Google Scholar 

  82. Harji DP, Sagar PM, Boyle K, Maslekar S, Griffiths B, McArthur DR. Outcome of surgical resection of second-time locally recurrent rectal cancer. Br J Surg. 2013;100(3):403–9.

    CAS  PubMed  Google Scholar 

  83. Carpenter SG, Stone WM, Bower TC, Fowl RJ, Money SR. Surgical management of tumors invading the aorta and major arterial structures. Ann Vasc Surg. 2011;25(8):1026–35.

    PubMed  Google Scholar 

  84. Austin KK, Solomon MJ. Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement. Dis Colon Rectum. 2009;52(7):1223–33.

    PubMed  Google Scholar 

  85. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE, et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum. 2006;49(8):1099–107.

    PubMed  Google Scholar 

  86. Rahbari NN, Ulrich AB, Bruckner T, Munter M, Nickles A, Contin P, et al. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg. 2011;253(3):522–33.

    PubMed  Google Scholar 

  87. Austin KK, Young JM, Solomon MJ. Quality of life of survivors after pelvic exenteration for rectal cancer. Dis Colon Rectum. 2010;53(8):1121–6.

    PubMed  Google Scholar 

  88. Harji DP, Griffiths B, Velikova G, Sagar PM, Brown J. Systematic review of health-related quality of life issues in locally recurrent rectal cancer. J Surg Oncol. 2015;111(4):431–8.

    Google Scholar 

  89. Cirocchi R, Trastulli S, Abraha I, Vettoretto N, Boselli C, Montedori A, et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;8, CD008997.

    Google Scholar 

  90. Allum WH, Mack P, Priestman TJ, Fielding JW. Radiotherapy for pain relief in locally recurrent colorectal cancer. Ann R Coll Surg Engl. 1987;69(5):220–1.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents. Br J Surg. 2002;89(9):1096–102.

    CAS  PubMed  Google Scholar 

  92. Spinelli P, Mancini A. Use of self-expanding metal stents for palliation of rectosigmoid cancer. Gastrointest Endosc. 2001;53(2):203–6.

    CAS  PubMed  Google Scholar 

  93. Colucci G, Gebbia V, Paoletti G, Giuliani F, Caruso M, Gebbia N, et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale. J Clin Oncol. 2005;23(22):4866–75.

    CAS  PubMed  Google Scholar 

  94. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol. 2004;22(1):23–30.

    CAS  PubMed  Google Scholar 

  95. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229–37.

    CAS  PubMed  Google Scholar 

  96. Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26(10):1626–34.

    CAS  PubMed  Google Scholar 

  97. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351(4):337–45.

    CAS  PubMed  Google Scholar 

  98. Giantonio BJ, Catalano PJ, Meropol NJ, O’Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007;25(12):1539–44.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Colon and Rectal Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Eric J. Dozois M.D.

  2. Department of Surgery, Section of Colon and Rectal Surgery, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Dorin T. Colibaseanu M.D.

Authors
  1. Eric J. Dozois M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dorin T. Colibaseanu M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric J. Dozois M.D. .

Editor information

Editors and Affiliations

  1. Division of Colorectal Surgery, University Hospitals Case Medical Center Case Western Reserve University, Cleveland, OH, USA

    Scott R. Steele

  2. Cleveland Clinic, Cleveland, OH, USA

    Tracy L. Hull

  3. Tufts University School of Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA

    Thomas E. Read

  4. Ambrose and Gladys Bowyer, Loyola University, Chicago, IL, USA

    Theodore J. Saclarides

  5. University of Texas Medical Branch at Galveston, Galveston, TX, USA

    Anthony J. Senagore

  6. Ochsner Medical Center, New Orleans, LA, USA

    Charles B. Whitlow

Rights and permissions

Reprints and permissions

Copyright information

© 2016 ASCRS (American Society of Colon and Rectal Surgeons)

About this chapter

Cite this chapter

Dozois, E.J., Colibaseanu, D.T. (2016). Colorectal Cancer: Management of Local Recurrence. In: Steele, S.R., Hull, T.L., Read, T.E., Saclarides, T.J., Senagore, A.J., Whitlow, C.B. (eds) The ASCRS Textbook of Colon and Rectal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-25970-3_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-25970-3_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-25968-0

  • Online ISBN: 978-3-319-25970-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation